190 related articles for article (PubMed ID: 35987730)
1. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma.
Khene ZE; Bigot P; Doumerc N; Ouzaid I; Boissier R; Nouhaud FX; Albiges L; Bernhard JC; Ingels A; Borchiellini D; Kammerer-Jacquet S; Rioux-Leclercq N; Roupret M; Acosta O; De Crevoisier R; Bensalah K;
Eur Urol Oncol; 2023 Jun; 6(3):323-330. PubMed ID: 35987730
[TBL] [Abstract][Full Text] [Related]
2. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
[TBL] [Abstract][Full Text] [Related]
3. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.
Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X
Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139
[TBL] [Abstract][Full Text] [Related]
4. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
[TBL] [Abstract][Full Text] [Related]
5. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
[TBL] [Abstract][Full Text] [Related]
6. [Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
Ji GW; Wang K; Xia YX; Li XC; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):679-685. PubMed ID: 34192861
[No Abstract] [Full Text] [Related]
7. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
9. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
10. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
11. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.
Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC
Front Oncol; 2023; 13():1106029. PubMed ID: 37007095
[TBL] [Abstract][Full Text] [Related]
13. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
14. Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
Correa AF; Jegede OA; Haas NB; Flaherty KT; Pins MR; Adeniran A; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Dutcher JP; DiPaola RS; Carducci MA; Uzzo RG
Eur Urol; 2021 Jul; 80(1):20-31. PubMed ID: 33707112
[TBL] [Abstract][Full Text] [Related]
15. The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study.
Xiao J; Mo M; Wang Z; Zhou C; Shen J; Yuan J; He Y; Zheng Y
JMIR Med Inform; 2022 Feb; 10(2):e33440. PubMed ID: 35179504
[TBL] [Abstract][Full Text] [Related]
16. Machine learning-based prediction of acute kidney injury after nephrectomy in patients with renal cell carcinoma.
Lee Y; Ryu J; Kang MW; Seo KH; Kim J; Suh J; Kim YC; Kim DK; Oh KH; Joo KW; Kim YS; Jeong CW; Lee SC; Kwak C; Kim S; Han SS
Sci Rep; 2021 Aug; 11(1):15704. PubMed ID: 34344909
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
18. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
19. Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma-A Prospective Cohort Study.
Gatto F; Dabestani S; Bratulic S; Limeta A; Maccari F; Galeotti F; Volpi N; Stierner U; Nielsen J; Lundstam S
Eur Urol Open Sci; 2022 Aug; 42():30-39. PubMed ID: 35911082
[TBL] [Abstract][Full Text] [Related]
20. Predicting Colorectal Cancer Survival Using Time-to-Event Machine Learning: Retrospective Cohort Study.
Yang X; Qiu H; Wang L; Wang X
J Med Internet Res; 2023 Oct; 25():e44417. PubMed ID: 37883174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]